Literature DB >> 19887461

Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study.

Anne E Cust1, Helen Schmid, Judith A Maskiell, Jodie Jetann, Megan Ferguson, Elizabeth A Holland, Chantelle Agha-Hamilton, Mark A Jenkins, John Kelly, Richard F Kefford, Graham G Giles, Bruce K Armstrong, Joanne F Aitken, John L Hopper, Graham J Mann.   

Abstract

Discovering and understanding genetic risk factors for melanoma and their interactions with phenotype, sun exposure, and other risk factors could lead to new strategies for melanoma control. This paper describes the Australian Melanoma Family Study, which uses a multicenter, population-based, case-control-family design. From 2001 to 2005, the authors recruited 1,164 probands including 629 cases with histopathologically confirmed, first-primary cutaneous melanoma diagnosed before age 40 years, 240 population-based controls frequency matched for age, and 295 spouse/friend controls. Information on lifetime sun exposure, phenotype, and residence history was collected for probands and nearly 4,000 living relatives. More than 3,000 subjects donated a blood sample. Proxy-reported information was collected for childhood sun exposure and deceased relatives. Important features of this study include the population-based, family-based design; a focus on early onset disease; probands from 3 major cities differing substantially in solar ultraviolet exposure and melanoma incidence; a population at high risk because of high ultraviolet exposure and susceptible pigmentation phenotypes; population-based, spouse/friend, and sibling controls; systematic recruitment of relatives of case and control probands; self and parent reports of childhood sun exposure; and objective clinical skin examinations. The authors discuss methodological and analytical issues related to the study design and conduct, as well as the potentially novel insights the study can deliver.

Entities:  

Mesh:

Year:  2009        PMID: 19887461      PMCID: PMC2800270          DOI: 10.1093/aje/kwp307

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  52 in total

Review 1.  Population-based family studies in genetic epidemiology.

Authors:  John L Hopper; D Timothy Bishop; Douglas F Easton
Journal:  Lancet       Date:  2005 Oct 15-21       Impact factor: 79.321

Review 2.  Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.

Authors:  Sara Gandini; Francesco Sera; Maria Sofia Cattaruzza; Paolo Pasquini; Roberto Zanetti; Cinzia Masini; Peter Boyle; Carmelo Francesco Melchi
Journal:  Eur J Cancer       Date:  2005-09       Impact factor: 9.162

3.  Public awareness about risk factors could pose problems for case-control studies: the example of sunbed use and cutaneous melanoma.

Authors:  E de Vries; M Boniol; G Severi; A M M Eggermont; P Autier; V Bataille; J F Doré; J W W Coebergh
Journal:  Eur J Cancer       Date:  2005-09       Impact factor: 9.162

4.  Ambient UV, personal sun exposure and risk of multiple primary melanomas.

Authors:  Anne Kricker; Bruce K Armstrong; Chris Goumas; Melisa Litchfield; Colin B Begg; Amanda J Hummer; Loraine D Marrett; Beth Theis; Robert C Millikan; Nancy Thomas; Hoda Anton Culver; Richard P Gallagher; Terence Dwyer; Timothy R Rebbeck; Peter A Kanetsky; Klaus Busam; Lynn From; Urvi Mujumdar; Roberto Zanetti; Marianne Berwick
Journal:  Cancer Causes Control       Date:  2007-01-06       Impact factor: 2.506

Review 5.  Participation rates in epidemiologic studies.

Authors:  Sandro Galea; Melissa Tracy
Journal:  Ann Epidemiol       Date:  2007-06-06       Impact factor: 3.797

6.  Assessing the influence of a genetic characteristic on disease in the presence of a strong environmental etiology.

Authors:  Noel S Weiss
Journal:  Epidemiology       Date:  2007-07       Impact factor: 4.822

7.  Common sequence variants on 20q11.22 confer melanoma susceptibility.

Authors:  Kevin M Brown; Stuart Macgregor; Grant W Montgomery; David W Craig; Zhen Zhen Zhao; Kelly Iyadurai; Anjali K Henders; Nils Homer; Megan J Campbell; Mitchell Stark; Shane Thomas; Helen Schmid; Elizabeth A Holland; Elizabeth M Gillanders; David L Duffy; Judith A Maskiell; Jodie Jetann; Megan Ferguson; Dietrich A Stephan; Anne E Cust; David Whiteman; Adele Green; Håkan Olsson; Susana Puig; Paola Ghiorzo; Johan Hansson; Florence Demenais; Alisa M Goldstein; Nelleke A Gruis; David E Elder; Julia Newton Bishop; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; Nicholas G Martin; Jeffrey M Trent; Graham J Mann; Nicholas K Hayward
Journal:  Nat Genet       Date:  2008-05-18       Impact factor: 38.330

8.  The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures.

Authors:  Amanda J Baxter; Maria Celia Hughes; Marina Kvaskoff; Victor Siskind; Sri Shekar; Joanne F Aitken; Adele C Green; David L Duffy; Nicholas K Hayward; Nicholas G Martin; David C Whiteman
Journal:  Twin Res Hum Genet       Date:  2008-04       Impact factor: 1.587

9.  Reproducibility of self-reported melanoma risk factors in a large cohort study of Norwegian women.

Authors:  Marit B Veierød; Christine L Parr; Eiliv Lund; Anette Hjartåker
Journal:  Melanoma Res       Date:  2008-02       Impact factor: 3.599

10.  The INTERPHONE study: design, epidemiological methods, and description of the study population.

Authors:  Elisabeth Cardis; Lesley Richardson; Isabelle Deltour; Bruce Armstrong; Maria Feychting; Christoffer Johansen; Monique Kilkenny; Patricia McKinney; Baruch Modan; Siegal Sadetzki; Joachim Schüz; Anthony Swerdlow; Martine Vrijheid; Anssi Auvinen; Gabriele Berg; Maria Blettner; Joseph Bowman; Julianne Brown; Angela Chetrit; Helle Collatz Christensen; Angus Cook; Sarah Hepworth; Graham Giles; Martine Hours; Ivano Iavarone; Avital Jarus-Hakak; Lars Klaeboe; Daniel Krewski; Susanna Lagorio; Stefan Lönn; Simon Mann; Mary McBride; Kenneth Muir; Louise Nadon; Marie-Elise Parent; Neil Pearce; Tiina Salminen; Minouk Schoemaker; Brigitte Schlehofer; Jack Siemiatycki; Masao Taki; Toru Takebayashi; Tore Tynes; Martie van Tongeren; Paolo Vecchia; Joe Wiart; Alistair Woodward; Naohito Yamaguchi
Journal:  Eur J Epidemiol       Date:  2007-07-18       Impact factor: 8.082

View more
  29 in total

1.  Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.

Authors:  Bhramar Mukherjee; John Oliver Delancey; Leon Raskin; Jessica Everett; Joanne Jeter; Colin B Begg; Irene Orlow; Marianne Berwick; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Hoda Anton Culver; Stefano Rosso; Roberto Zanetti; Peter A Kanetsky; Lynn From; Stephen B Gruber
Journal:  J Natl Cancer Inst       Date:  2012-04-24       Impact factor: 13.506

2.  Practical and analytical aspects of using friend controls in case-control studies: experience from a case-control study of childhood cancer.

Authors:  Greta R Bunin; Saran Vardhanabhuti; Agueda Lin; Greta L Anschuetz; Nandita Mitra
Journal:  Paediatr Perinat Epidemiol       Date:  2011-07-19       Impact factor: 3.980

3.  Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.

Authors:  Peter A Johansson; Vaishnavi Nathan; Lauren M Bourke; Jane M Palmer; Tongwu Zhang; Judith Symmons; Madeleine Howlie; Ann-Marie Patch; Jazlyn Read; Elizabeth A Holland; Helen Schmid; Sunil Warrier; William Glasson; Veronica Höiom; Karin Wadt; Göran Jönsson; Håkan Olsson; Christian Ingvar; Graham Mann; Kevin M Brown; Nicholas K Hayward; Antonia L Pritchard
Journal:  Melanoma Res       Date:  2019-10       Impact factor: 3.599

4.  Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk.

Authors:  Hongliang Liu; Li-E Wang; Zhensheng Liu; Wei V Chen; Christopher I Amos; Jeffrey E Lee; Mark M Iles; Matthew H Law; Jennifer H Barrett; Grant W Montgomery; John C Taylor; Stuart MacGregor; Anne E Cust; Julia A Newton Bishop; Nicholas K Hayward; D Timothy Bishop; Graham J Mann; Paul Affleck; Qingyi Wei
Journal:  Carcinogenesis       Date:  2013-01-04       Impact factor: 4.944

5.  Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian adults.

Authors:  Anne E Cust; Kristen M Pickles; Chris Goumas; Thao Vu; Helen Schmid; Eduardo Nagore; John Kelly; Joanne F Aitken; Graham G Giles; John L Hopper; Mark A Jenkins; Graham J Mann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-27       Impact factor: 4.254

6.  Sunscreen Use and Melanoma Risk Among Young Australian Adults.

Authors:  Caroline G Watts; Martin Drummond; Chris Goumas; Helen Schmid; Bruce K Armstrong; Joanne F Aitken; Mark A Jenkins; Graham G Giles; John L Hopper; Graham J Mann; Anne E Cust
Journal:  JAMA Dermatol       Date:  2018-09-01       Impact factor: 10.282

7.  Low accuracy of self-reported family history of melanoma in high-risk patients.

Authors:  Nicholas D Flint; Michael D Bishop; Tristan C Smart; Jennifer L Strunck; Kenneth M Boucher; Douglas Grossman; Aaron M Secrest
Journal:  Fam Cancer       Date:  2021-01       Impact factor: 2.375

8.  Occupational sun exposure and risk of melanoma according to anatomical site.

Authors:  Kylie Vuong; Kevin McGeechan; Bruce K Armstrong; Anne E Cust
Journal:  Int J Cancer       Date:  2013-11-29       Impact factor: 7.396

9.  Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines.

Authors:  K Vuong; B K Armstrong; M Drummond; J L Hopper; J H Barrett; J R Davies; D T Bishop; J Newton-Bishop; J F Aitken; G G Giles; H Schmid; M A Jenkins; G J Mann; K McGeechan; A E Cust
Journal:  Br J Dermatol       Date:  2019-09-22       Impact factor: 9.302

10.  Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies.

Authors:  Katherine S Elliott; Eleftheria Zeggini; Mark I McCarthy; Julius Gudmundsson; Patrick Sulem; Simon N Stacey; Steinunn Thorlacius; Laufey Amundadottir; Henrik Grönberg; Jianfeng Xu; Valerie Gaborieau; Rosalind A Eeles; David E Neal; Jenny L Donovan; Freddie C Hamdy; Kenneth Muir; Shih-Jen Hwang; Margaret R Spitz; Brent Zanke; Luis Carvajal-Carmona; Kevin M Brown; Nicholas K Hayward; Stuart Macgregor; Ian P M Tomlinson; Mathieu Lemire; Christopher I Amos; Joanne M Murabito; William B Isaacs; Douglas F Easton; Paul Brennan; Rosa B Barkardottir; Daniel F Gudbjartsson; Thorunn Rafnar; David J Hunter; Stephen J Chanock; Kari Stefansson; John P A Ioannidis
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.